320
Views
6
CrossRef citations to date
0
Altmetric
Original Article: Research

A comparative proteomic study of Homoharringtonine-induced apoptosis in leukemia K562 cells

, , , , , , , , , & show all
Pages 2162-2169 | Received 10 Feb 2014, Accepted 12 Oct 2014, Published online: 14 Jan 2015

References

  • Quintas-Cardama A, Kantarjian H, Cortes J. Homoharringtonine, omacetaxine mepesuccinate, and chronic myeloid leukemia circa 2009. Cancer 2009;115:5382–5393.
  • Kantarjian HM, Talpaz M, Santini V, et al. Homoharringtonine: history, current research, and future direction. Cancer 2001;92: 1591–1605.
  • Quintas-Cardama A, Kantarjian H, Garcia-Manero G, et al. Phase I/II study of subcutaneous homoharringtonine in patients with chronic myeloid leukemia who have failed prior therapy. Cancer 2007;109:248–255.
  • Chen Y, Peng C, Sullivan C, et al. Novel therapeutic agents against cancer stem cells of chronic myeloid leukemia. Anticancer Agents Med Chem 2010;10:111–115.
  • Yinjun L, Jie J, Weilai X, et al. Homoharringtonine mediates myeloid cell apoptosis via upregulation of pro-apoptotic bax and inducing caspase-3-mediated cleavage of poly(ADP-ribose) polymerase (PARP). Am J Hematol 2004;76:199–204.
  • Kuliczkowski K. Influence of harringtonine on human leukemia cell differentiation. Arch Immunol Ther Exp (Warsz) 1989;37:69–76.
  • Fresno M, Jimenez A, Vazquez D. Inhibition of translation in eukaryotic systems by harringtonine. Eur J Biochem 1977;72:323–330.
  • Li R, Liu XL, Du QF, et al. [Experimental study of K562 cell apoptosis induced by harringtonine]. Di Yi Jun Yi Da Xue Xue Bao 2002;22:788–790.
  • Nicolini FE, Chomel JC, Roy L, et al. The durable clearance of the T315I BCR-ABL mutated clone in chronic phase chronic myelogenous leukemia patients on omacetaxine allows tyrosine kinase inhibitor rechallenge. Clin Lymphoma Myeloma Leuk 2010;10: 394–399.
  • Visani G, Russo D, Ottaviani E, et al. Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on “in vitro” growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitors. Leukemia 1997;11:624–628.
  • Jie H, Donghua H, Xingkui X, et al. Homoharringtonine-induced apoptosis of MDS cell line MUTZ-1 cells is mediated by the endoplasmic reticulum stress pathway. Leuk Lymphoma 2007;48:964–977.
  • Tang R, Faussat AM, Majdak P, et al. Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells. Mol Cancer Ther 2006;5:723–731.
  • Tait SW, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010;11:621–632.
  • Galluzzi L, Vitale I, Abrams JM, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012;19:107–120.
  • Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008;9:47–59.
  • Sprick MR, Walczak H. The interplay between the Bcl-2 family and death receptor-mediated apoptosis. Biochim Biophys Acta 2004;1644:125–132.
  • Galban S, Duckett CS. XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ 2010;17:54–60.
  • Kuroda J, Kamitsuji Y, Kimura S, et al. Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and beta-catenin. Int J Hematol 2008;87:507–515.
  • Wakasugi K, Nakano T, Morishima I. Oxidative stress-responsive intracellular regulation specific for the angiostatic form of human tryptophanyl-tRNA synthetase. Biochemistry 2005;44:225–232.
  • Kisselev LL. Mammalian tryptophanyl-tRNA synthetases. Biochimie 1993;75:1027–1039.
  • Kanno M, Chalut C, Egly JM. Genomic structure of the putative BTF3 transcription factor. Gene 1992;117:219–228.
  • McClung JK, Jupe ER, Liu XT, et al. Prohibitin: potential role in senescence, development, and tumor suppression. Exp Gerontol 1995;30:99–124.
  • Christians ES, Yan LJ, Benjamin IJ. Heat shock factor 1 and heat shock proteins: Critical partners in protection against acute cell injury. Crit Care Med 2002;30:S43–S50.
  • Pratt WB, Gehring U, Toft DO. Molecular chaperoning of steroid hormone receptors. EXS 1996;77:79–95.
  • Khong T, Spencer A. Targeting HSP 90 induces apoptosis and inhibits critical survival and proliferation pathways in multiple myeloma. Mol Cancer Ther 2011;10:1909–1917.
  • Mjahed H, Girodon F, Fontenay M, et al. Heat shock proteins in hematopoietic malignancies. Exp Cell Res 2012;318:1946–1958.
  • Lanneau D, Brunet M, Frisan E, et al. Heat shock proteins: essential proteins for apoptosis regulation. J Cell Mol Med 2008;12:743–761.
  • Jin W, Wu J, Zhuang Z, et al. Gene expression profiling in apoptotic k562 cells treated by homoharringtonine. Acta Biochim Biophys Sin (Shanghai) 2007;39:982–991.
  • Mitsumoto A, Nakagawa Y. DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. Free Radic Res 2001;35:885–893.
  • Nagakubo D, Taira T, Kitaura H, et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 1997;231:509–513.
  • Kim RH, Peters M, Jang Y, et al. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 2005;7:263–273.
  • Junn E, Taniguchi H, Jeong BS, et al. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc Natl Acad Sci USA 2005;102:9691–9696.
  • Liu H, Wang M, Li M, et al. Expression and role of DJ-1 in leukemia. Biochem Biophys Res Commun 2008;375:477–483.
  • Lu J, Holmgren A. Thioredoxin system in cell death progression. Antioxid Redox Signal 2012;17:1738–1747.
  • Lee S, Kim SM, Lee RT. Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance. Antioxid Redox Signal 2013;18:1165–1207.
  • Saitoh M, Nishitoh H, Fujii M, et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998;17:2596–2606.
  • Deng WG, Nishizaki M, Fang B, et al. Induction of apoptosis by tumor suppressor FHIT via death receptor signaling pathway in human lung cancer cells. Biochem Biophys Res Commun 2007;355:993–999.
  • Askari MD, Vo-Dinh T. Implication of mitochondrial involvement in apoptotic activity of fragile histidine triad gene: application of synchronous luminescence spectroscopy. Biopolymers 2004;73: 510–523.
  • Costantini P, Jacotot E, Decaudin D, et al. Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst 2000;92:1042–1053.
  • Trapasso F, Pichiorri F, Gaspari M, et al. Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cells. J Biol Chem 2008;283:13736–13744.
  • de Vries JE, ten Kate J, Bosman FT. p21ras in carcinogenesis. Pathol Res Pract 1996;192:658–668.
  • Wang HG, Miyashita T, Takayama S, et al. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene 1994;9: 2751–2756.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.